Exagamglogene autotemcel (exa-cel), a CRISPR/Cas9 gene-edited cell therapy, eliminated vaso-occlusive crises in 97% of participants with severe sickle cell disease. The therapy led to substantial ...
A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as ...
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...
Hoosiers from across the state will gather at the Indiana State Capitol on Monday, Feb. 2, to call attention to the urgent ...
Sickle cell disease (SCD) can affect people of any ethnicity but is much more common among Africans and African Americans. Other ethnic groups with higher rates of SCD include Hispanic Americans from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results